Abstract
Itaconic acid is an unsaturated dicarbonic acid which has a high potential as a biochemical building block, because it can be used as a monomer for the production of a plethora of products including resins, plastics, paints, and synthetic fibers. Some Aspergillus species, like A. itaconicus and A. terreus, show the ability to synthesize this organic acid and A. terreus can secrete significant amounts to the media (>80 g/L). However, compared with the citric acid production process (titers >200 g/L) the achieved titers are still low and the overall process is expensive because purified substrates are required for optimal productivity. Itaconate is formed by the enzymatic activity of a cis-aconitate decarboxylase (CadA) encoded by the cadA gene in A. terreus. Cloning of the cadA gene into the citric acid producing fungus A. niger showed that it is possible to produce itaconic acid also in a different host organism. This review will describe the current status and recent advances in the understanding of the molecular processes leading to the biotechnological production of itaconic acid.
INTRODUCTION
Itaconic acid (2-methylidenebutanedioic acid) is an unsaturated di-carbonic acid. It has a broad application spectrum in the industrial production of resins and is used as a building block for acrylic plastics, acrylate latexes, super-absorbents, and anti-scaling agents (; ). Since the 1960s the production of itaconic acid is achieved by the fermentation with Aspergillus terreus on sugar containing media (). Although also other microorganisms like Ustilago zeae (), U. maydis, Candida sp. (), and Rhodotorula sp. () were found to produce itaconic acid, A. terreus is still the dominant production host, because so far only bred strains of this species can reach levels of up to 80–86 g/L (; ). Since the 1990s, itaconic acid as a renewable material is attracting a lot of interest. Although the production costs for itaconic acid are declining in the last years ($ 4 per kg in 2001; ), it is still a valuable product with an estimated price of $ 2 per kg. Currently, the worldwide production capacity of itaconic acid is expected to be about 50 kt per year, facing a demand of about 30 kt (Shaw, 2013, Itaconix Corporation, personal communication). Especially, for the production of polymers it is of interest, because in the future it can function as a substitute for acrylic and methacrylic acid used for the production of plastics (). However, these applications require an even lower price of the starting material. The current knowledge about the biotechnological production of itaconic acid was recently reviewed (; ). The latter review covers the industrial production of itaconic acid and the applications of this product. Therefore, we focus in this report on the recent advances with an emphasis on the biochemistry of the process and new genetic engineering targets. For rational strain improvement, it is essential to understand the underlying biological concepts and biochemical pathways leading to the production of this important organic acid in microorganisms.
BIOSYNTHESIS PATHWAY
recognized that a filamentous fungus was able to produce itaconic acid and consequently described this species as A. itaconicus. The biosynthesis of itaconic acid was for a long time hotly debated, because it was not clear whether itaconic acid arises from a pathway including parts of the tricarboxylic acid (TCA) cycle or an alternative pathway via citramalate or the condensation of acetyl-CoA.
proposed a pathway for the biosynthesis of itaconic acid, which is depicted in Figure 1. Starting from a sugar substrate like glucose the carbon molecules are processed via glycolysis to pyruvate. Then the pathway is split and part of the carbon is metabolized to Acetyl-CoA releasing a carbon dioxide molecule. The other part is converted to oxaloacetate so that the previously released carbon dioxide molecule is again incorporated. In the first steps of the citric acid cycle, citrate and cis-aconitate are formed. In the last step, the only itaconic acid pathway dedicated step, cis-aconitate decarboxylase (CadA) forms itaconic acid releasing carbon dioxide. This pathway was confirmed by tracer experiments with 14C and 13C labeled substrates (; ; ) and also the necessary enzymatic activities have been all determined ().
FIGURE 1
The formation of carboxylic acids, like citric and itaconic acid, involves the shuttling of intermediate metabolites between different intracellular compartments and utilizes the different enzymatic capabilities of the respective compartment. In case of itaconic acid the compartmentalization of the pathway was analyzed by fractionized cell extracts distinguishing the enzymatic activity of a mitochondrial from a cytosolic enzyme. It was found that the key enzyme of the pathway, CadA, is not located in the mitochondria but in the cytosol (), whereas the enzymes preceding in the pathway, namely citrate synthase and aconitase, are found in the mitochondria. However, a residual level of aconitase and citrate synthase activity is also found in the cytosolic fraction. The proposed mechanism is that cis-aconitate is transported via the malate–citrate antiporter into the cytosol (). However, so far it was not shown whether cis-aconitate makes use of the mitochondrial malate–citrate antiporter or uses another mitochondrial carrier protein to be translocated to the cytosol.
Besides A. terreus, itaconic acid is known to be produced also by other fungi like U. zeae (), U. maydis (; ), Candida sp. (), and Rhodotorula sp. (). No further investigations exist about the underlying reaction principles leading to itaconic acid formation in those species. However, recent evidence (; ) points into the direction that CadA activity constitutes the general pathway toward the formation of itaconic acid in nature. Very recently, itaconic acid was detected in mammalian cells, where it was found in macrophage-derived cells (). Those cells also possess a CadA activity and have the ability to form itaconic acid de novo. But, up to now no specific gene encoding this enzymatic activity was identified in mammalian cells.
However, the physiological role of itaconic acid in mammalian cells is still unknown. speculate on the role of itaconic acid as an inhibitor of metabolic pathways, because it is described as an enzymatic inhibitor. On the one hand, itaconic acid is known to inhibit isocitrate lyase (; ), which is the crucial part of the glyoxylate shunt, and thus can act as an antibacterial agent. On the other hand, itaconic acid can inhibit fructose-6-phosphate 2-kinase () and thus have a direct influence on the central carbon metabolism. In rats it was shown that a itaconate diet leads to a reduced visceral fat accumulation, because of a suppressed glycolytic flux ().
ITACONIC ACID PATHWAY SPECIFIC ENZYMES AND GENES
The reaction catalyzed by the cis-aconitic acid decarboxylase was already described in 1957 (,). Subsequently performed 13C and 14C labeling experiments (; ) confirmed the reaction scheme depicted in Figure 2. Itaconic acid is formed by an allylic rearrangement and decarboxylation from cis-aconitic acid removing either carbon C1 or C5 from the starting citric acid molecule (because of the symmetry of the molecule).
FIGURE 2
Furthermore, certain properties of the A. terreus CadA enzyme were determined: it has a Km value of 2.45 mM (37°C, pH 6.2) and a pH optimum of 6.2 (
In contrast to the enzyme purification strategy,
The activity of the cis-aconitic acid decarboxylase is crucial for the performance of the whole itaconic acid biosynthesis pathway. In an itaconic acid overproducing strain, which was obtained by an selection on high itaconate levels (
CATABOLIZATION OF ITACONIC ACID
Much is known about the biosynthesis of itaconic acid and the underlying enzymatic mechanisms, but for a complete biochemical picture of a certain metabolite, also the knowledge about its degradation is necessary. Unfortunately, the information about the degradation pathway of itaconic acid is scarce. In mammalian cells (guinea pig and rat liver) it was found that itaconate is converted to itaconyl-CoA (
METABOLIC ENGINEERING OF THE ITACONIC ACID PATHWAY IN A. terreus AND A. niger
The levels of itaconic acid which were reached with A. terreus are currently limited to about 85 g/L. Although this is already a substantial amount it cannot be compared with the production of citric acid where titers over 200 g/L are steadily obtained in industrial processes. Transferred to the itaconic acid production a maximal theoretical titer of about 240 g/L should be achievable (
In A. terreus, a gene was shown to influence the performance of itaconic acid production, which is a key enzyme of glycolysis. 6-phosphofructo-1-kinase is known to be inhibited by citrate and adenosine triphosphate (ATP). However, a truncated version of the A. niger pfkA gene was shown to exhibit a higher citric acid yield due to a reduced inhibition by citrate and ATP (
There is the possibility that the genetic make-up of A. terreus is not efficient enough to support the production of higher titers of organic acids. Therefore, a strategy is to genetically engineer the itaconic acid biosynthesis pathway into another host organism, which is already known to support the production of high titers of organic acids. As already mentioned, A. niger is such a candidate. The unique and crucial step in the biosynthesis pathway is the decarboxylation of cis-aconitic acid toward itaconic acid. When the cadA gene (
OUTLOOK
Itaconic acid as a renewable organic acid is of growing interest for the chemical industry, because of its potential to replace crude oil based products like acrylic acid. Up to now, the microorganism based processes were improved by classical strain breeding and optimizations of the fermentation strategies and conditions. Especially the knowledge about the biotechnological process including oxygen supply, media compositions, and different bioreactor systems was significantly expanded (
The investigations on the molecular principles of itaconic acid synthesis revealed that cis-aconitic acid decarboxylase is the dedicated step in its biosynthesis in A. terreus. Genetic engineering of this enzymatic step also renders other microbial hosts like A. niger to producers of itaconic acid.
Statements
Acknowledgments
This work has been financially supported by the FHplus (project METORGANIC) and by the program Intelligente Produktion (project Lignorefinery) donated by the Austrian Research Promotion Agency FFG. Furthermore, this work has been supported by the Federal Ministry of Economy, Family and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation and Technology (bmvit), the Styrian Business Promotion Agency SFG, the Standortagentur Tirol and ZIT – Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
REFERENCES
1
AdlerJ.WangS. F.LardyH. A. (1957). The metabolism of itaconic acid by liver mitochondria.J. Biol. Chem.229865–879.
2
BentleyR.ThiessenC. P. (1957a). Biosynthesis of itaconic acid in Aspergillus terreus. I. Tracer studies with C14-labeled substrates.J. Biol. Chem.226673–687.
3
BentleyR.ThiessenC. P. (1957b). Biosynthesis of itaconic acid in Aspergillus terreus. III. The properties and reaction mechanism of cis-aconitic acid decarboxylase.J. Biol. Chem.226703–720.
4
BlumhoffM.SteigerM. G.MarxH.MattanovichD.SauerM. (2013). Six novel constitutive promoters for metabolic engineering of Aspergillus niger.Appl. Microbiol. Biotechnol.97259–267.
5
BonnarmeP.GilletB.SepulchreA. M.RoleC.BeloeilJ. C.DucrocqC. (1995). Itaconate biosynthesis in Aspergillus terreus.J. Bacteriol.1773573–3578.
6
CapuderM.SolarT.BencinaM.LegisaM. (2009). Highly active, citrate inhibition resistant form of Aspergillus niger 6-phosphofructo-1-kinase encoded by a modified pfkA gene.J. Bacteriol.14451–57.
7
CooperR.KornbergH. L. (1964). The utilization of itaconate by Pseudomonas sp.Biochem. J.9182–91.
8
DwiartiL.YamaneK.YamataniH.KaharP.OkabeM. (2002). Purification and characterization of cis-aconitic acid decarboxylase from Aspergillus terreus TN484-M1.J. Biosci. Bioeng.9429–33.
9
FriedmannS.AlberB. E.FuchsG. (2007). Properties of R-citramalyl-coenzyme A lyase and its role in the autotrophic 3-hydroxypropionate cycle of Chloroflexus aurantiacus.J. Bacteriol.1892906–2914.
10
HaskinsR. H.ThornJ. A.BoothroydB. (1955). Biochemistry of the Ustilaginales: XI. Metabolic products of Ustilago zeae in submerged culture.Can. J. Microbiol.1749–756.
11
JainR. K. (1996). The molecular cloning of genes specifying some enzymes of the 3,5-xylenol degradative pathway.Appl. Microbiol. Biotechnol.45502–508.
12
JaklitschM.KubicekP.ScruttonC.LondonC.RoadC. H.LondonW. (1991). The subcellular organization of itaconate biosynthesis Aspergillus terreus.J. Gen. Microbiol.137533–539.
13
JoreJ. P. M.PuntP. J.Van Der WerfM. J. (2011). Production of Itaconic Acid. Nederlandse organisatie voor toegepast-naturrweteenschappelijk onderzoek.US Patent 20110124066 A1.
14
KanamasaS.DwiartiL.OkabeM.ParkE. Y. (2008). Cloning and functional characterization of the cis-aconitic acid decarboxylase (CAD) gene from Aspergillus terreus.Appl. Microbiol. Biotechnol.80223–229.
15
KawamuraD.FuruhashiM.SaitoOMatsuiH. (1981). Production of Itaconic Acid by Fermentation.Shizuoka Prefecture; Iwata Kagaku Kogyo Japan Patent 56137893.
16
KinoshitaK. (1932). Über die Produktion von Itaconsäure und Mannit durch einen neuen Schimmelpilz, Aspergillus itaconicus.Acta Phytochimica.5271–287.
17
KlementT.MilkerS.JägerG.GrandeP. M.Domínguez de MaríaPBüchsJ. (2012). Biomass pretreatment affects Ustilago maydis in producing itaconic acid.Microb. Cell Fact.1143.
18
KuenzA.GallenmüllerY.WillkeT.VorlopK.-D. (2012). Microbial production of itaconic acid: developing a stable platform for high product concentrations.Appl. Microbiol. Biotechnol.961209–1216.
19
LiA.Van LuijkN.Ter BeekM.CaspersM.PuntPVan der WerfM. (2011). A clone-based transcriptomics approach for the identification of genes relevant for itaconic acid production in Aspergillus.Fungal Genet. Biol.48602–611.
20
LiA.PfelzerN.ZuijderwijkR.PuntP. J. (2012). Enhanced itaconic acid production in Aspergillus niger using genetic modification and medium optimization.BMC Biotechnol.12:57. 10.1186/1472-6750-12-57
21
LinY.-H.LiY.-F.HuangM.-C.TsaiY.-C. (2004). Intracellular expression of Vitreoscilla hemoglobin in Aspergillus terreus to alleviate the effect of a short break in aeration during culture.Biotechnol. Lett.261067–1072.
22
McFaddenB. A.PurohitS. (1977). Itaconate, an isocitrate lyase-directed inhibitor in Pseudomonas indigofera.J. Bacteriol.131136–144.
23
NagaiJ. (1963). Studies on itaconate metabolism. II. Citramalate metabolism in Pseudomonas fluorescens grown on itaconate.J. Biochem.5434–40.
24
OkabeM.LiesD.KanamasaS.ParkE. Y. (2009). Biotechnological production of itaconic acid and its biosynthesis in Aspergillus terreus.Appl. Microbiol. Biotechnol.84597–606.
25
SakaiA.KusumotoA.KisoY.FuruyaE. (2004). Itaconate reduces visceral fat by inhibiting fructose 2,6-bisphosphate synthesis in rat liver.Nutrition20997–1002.
26
SchürmannM.WübbelerJ. H.GroteJSteinbüchelA. (2011). Novel reaction of succinyl coenzyme A (Succinyl-CoA) synthetase: activation of 3-sulfinopropionate to 3-sulfinopropionyl-CoA in Advenella mimigardefordensis strain DPN7T during degradation of 3,3′-dithiodipropionic acid.J. Bacteriol.1933078–3089.
27
StrelkoC. L.LuW.DufortF. J.SeyfriedT. N.ChilesT. C.RabinowitzJ. D.et al (2011). Itaconic acid is a mammalian metabolite induced during macrophage activation.J. Am. Chem. Soc.13316386–16389.
28
TabuchiT.SugisawaT.IshidorT.NakaharaT.SugiyamaJ. (1981). Itaconic acid fermentation by a yeast belonging to the genus Candida.Agric. Biol. Chem.45475–479.
29
TevzG.BencinaM.LegisaM. (2010). Enhancing itaconic acid production by Aspergillus terreus.Appl. Microbiol. Biotechnol.871657–1664.
30
Van der StraatL.LammersM.VernooijM.Van den BergW.CordewenerJ.VermeerI.et al (2012). “Effective production of Itaconic Acid in Aspergillus niger,” inSymposium on Bio-based Production of Organic Acids(Frankfurt, Germany), 12.
31
VollA.KlementT.GerhardsG.BüchsJ.MarquardtW. (2012). Metabolic modelling of itaconic acid fermentation with Ustilago maydis.Chem. Eng. Trans.27367–372.
32
WangS. F.AdlerJ.LardyH. A. (1961). The pathway of itaconate metabolism by liver mitochondria.J. Biol. Chem.23626–30.
33
WilliamsJ. O.RocheT. E.McFaddenB. A. (1971). Mechanism of action of isocitrate lyase from Pseudomonas indigofera.Biochemistry101384–1390.
34
WillkeT.VorlopK.-D. (2001). Biotechnological production of itaconic acid.Appl. Microbiol. Biotechnol.56289–295.
35
WinskillN. (1983). Tricarboxylic acid cycle activity in relation to itaconic acid biosynthesis by Aspergillus terreus.J. Gen. Microbiol.1292877–2883.
36
YahiroK.TakahamaT.ParkY. S.OkabeM. (1995). Breeding of Aspergillus terreus mutant TN-484 for itaconic acid production with high yield.J. Ferment. Bioeng.79506–508.
Summary
Keywords
cis-aconitic acid decarboxylase, Aspergillus terreus, Aspergillus niger, metabolic engineering, biochemical pathways, microbial organic acid production, industrial microbiology
Citation
Steiger MG, Blumhoff ML, Mattanovich D and Sauer M (2013) Biochemistry of microbial itaconic acid production. Front. Microbio. 4:23. doi: 10.3389/fmicb.2013.00023
Received
11 January 2013
Accepted
29 January 2013
Published
14 February 2013
Volume
4 - 2013
Edited by
Nuno P. Mira, Instituto Superior Técnico; Institute for Biotechnology and Bioengineering, Portugal
Reviewed by
Laura R. Jarboe, Iowa State University, USA; Peter Punt, TNO, Netherlands
Copyright
© Steiger, Blumhoff, Mattanovich and Sauer.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
*Correspondence: Matthias G. Steiger, Department of Biotechnology, BOKU – Vienna Institute of BioTechnology, University of Natural Resources and Life Sciences, Muthgasse 18, 1190 Vienna, Austria. e-mail: matthias.steiger@boku.ac.at
This article was submitted to Frontiers in Microbial Physiology and Metabolism, a specialty of Frontiers in Microbiology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.